3.625USD-14.50%Mkt Cap: 48.26M USDP/E: —Last update: 2026-06-01
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United Sta…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap48.26M USD
Enterprise Value36.76M USD
Revenue (TTM)—
Gross Profit-9.74M USD
Net Income (TTM)-22.45M USD
Revenue/Share—
Last Price3.625 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.56
PEG—
EV/EBITDA-1.55
EV/Revenue—
P/S—
P/B2.63
EPS (TTM)-4.33
EPS (Forward)-1.17
52W Range
3.1605% of range11.89
52W High11.89 USD
52W Low3.160 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-894.81%
ROA-148.94%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.25M USD
CapEx (TTM)162.14K USD
FCF Margin—
FCF Yield-24.70%
Net Debt-18.46M USD
Net Debt/EBITDA0.78
Balance Sheet
Debt/Equity3.50
Current Ratio2.55
Quick Ratio2.37
Book Value/Sh1.584 USD
Cash/Share1.950 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateAug 9, 2024
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)24.92 USD
Target Range8.000 USD – 55.00 USD
# Analysts6
Ownership
Shares Out.13.28M
Float12.94M
Insiders30.97%
Institutions8.99%
Short Interest
Short Ratio3.3d
Short % Float14.25%
Short % Out.11.88%
Shares Short1.58M
Short (prev mo.)1.42M
Technical
SMA 505.510 (-34.2%)
SMA 2004.904 (-26.1%)
Beta-0.81
S&P 52W Chg27.94%
Avg Vol (30d)568.79K
Avg Vol (10d)620.06K
Technical Indicators
RSI (14)40.9
MACD-0.3421
MACD Signal-0.3357
MACD Hist.-0.0065
BB Upper5.575 USD
BB Middle4.751 USD
BB Lower3.927 USD
BB Width34.68%
ATR (14)0.5235 USD
Vol Ratio (20d)1.69x